An Open, Multicentre, Randomised, Parallel Group Study to Compare in Marginal Old-for-old Renal Transplant Patients the Safety and Efficacy of Two Treatments: Sequential Mycophenolate Mofetil/Delayed Tacrolimus Plus Steroids vs Tacrolimus Plus Mycophenolate Mofetil in Patients Requiring Induction With Anti-IL2 Antibody
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Tacrolimus (Primary) ; Corticosteroids; Mycophenolate mofetil
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Acronyms TIGRE
- Sponsors Astellas Pharma
- 14 Apr 2009 Actual end date (Mar 2008) added as reported by ClinicalTrials.gov.
- 14 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Aug 2008 Planned end date changed from Mar 2008 to Dec 2008, as reported by ClinicalTrials.gov.